Testing effectiveness (Phase 2)Study completedNCT03192202What this trial is testingAFM13 in Relapsed/Refractory Cutaneous LymphomasWho this might be right forLymphoma, T-Cell, Cutaneous Ahmed Sawas 18
Early research (Phase 1)Ended earlyNCT00369629What this trial is testingGemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary SyndromeWho this might be right forLymphoma Northwestern University 14
Early research (Phase 1)Study completedNCT00006009What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent LymphomaWho this might be right forLymphomaSmall Intestine Cancer Stanford University
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Not applicableStudy completedNCT00408681What this trial is testingLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00047164What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine TherapyWho this might be right forLymphoma National Institutes of Health Clinical Center (CC) 89
Testing effectiveness (Phase 2)Study completedNCT00448357What this trial is testingAllogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 54
Early research (Phase 1)Ended earlyNCT00023790What this trial is testingPhotodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the SkinWho this might be right forBreast CancerHead and Neck CancerLymphoma+3 more Case Comprehensive Cancer Center 3
Large-scale testing (Phase 3)UnknownNCT00020865What this trial is testingLevofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and NeutropeniaWho this might be right forFever, Sweats, and Hot FlashesInfectionLeukemia+3 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03409432What this trial is testingBrentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell LymphomaWho this might be right forLymphomatoid PapulosisPrimary Cutaneous Anaplastic Large Cell LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma+6 more John Reneau 26
Early research (Phase 1)Study completedNCT00049400What this trial is testingS0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver DysfunctionWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific SWOG Cancer Research Network 78
Early research (Phase 1)Ended earlyNCT00671112What this trial is testingEverolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaWho this might be right for714leukemiaLymphoma Brian Hill, MD, PhD 30
Testing effectiveness (Phase 2)UnknownNCT00008164What this trial is testingUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaWho this might be right forChildhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more Herbert Irving Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00474929What this trial is testingSorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm Mayo Clinic 103
Early research (Phase 1)Study completedNCT01134341What this trial is testingPralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaWho this might be right forCutaneous T-cell LymphomaMycosis FungoidesSezary Syndrome+1 more Acrotech Biopharma Inc. 34
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62
Not applicableStudy completedNCT00376922What this trial is testingMusic in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+7 more Wake Forest University Health Sciences 65
Early research (Phase 1)Study completedNCT00004189What this trial is testingRebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced CancerWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT00003613What this trial is testingO6-benzylguanine and Carmustine in Treating Patients With Stage IA-IIA Cutaneous T-cell LymphomaWho this might be right forRecurrent Cutaneous T-cell Non-Hodgkin LymphomaStage I Cutaneous T-cell Non-Hodgkin LymphomaStage II Cutaneous T-cell Non-Hodgkin Lymphoma National Cancer Institute (NCI) 20